Skip to content
Tuesday 8 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,822.13
-0.08%
DAX
26,006.53
0.00%
CAC 40
8,306.15
0.00%
STOXX 50
6,403.99
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 15 December 2021 11:35 am  |  Updated:  Saturday 18 December 2021 12:34 pm

4C Labs a step closer to launch of UK medical cannabis clinics

By: Lily Russell-Jones

Add as a preferred source on Google
Cannabis

4C Labs has become the first company to obtain permissions to both cultivate and sell medicinal cannabis in the UK.

Patients will be able to book online consultations with doctors who can prescribe them medicinal cannabis over the internet 4C Labs said in a statement today. Last month the company was granted a license to build a 40,000 square foot weed farm in Guernsey which will help 4C to provide the UK market with “consistent access” to cannabis-based medicines.

Greg Dobbin, the chief executive of 4C LABS, said, “we are extremely excited to have successfully registered our virtual clinic; this is a major step
forward for patients who are eligible for medical cannabis, as well as those who are looking for an integrated approach to treatment that considers all aspects of wellbeing.

“We are developing a leading digital platform enabling automated scheduling, one click records retrieval and digital prescriptions, to significantly streamline the process. To make the process easy for patients, we have simplified the patient pathway to dramatically reduce the time between consultation and prescription delivery,” said Dobbin referring to plans to create a next day cannabis delivery service for UK patients.

Medicinal cannabis growth and use first became legal in the UK back in 2018, however it is yet to be prescribed to patients on a wide scale.

Only a handful of NHS CBPM prescriptions have been issued with the vast majority coming from the private system which means high costs for appointments, assessments and medicines. Meanwhile millions of Britons are seeking out cannabis based products, using CBD purchased at their local pharmacy or health food store.

In a sign that UK legislators are warming up to the idea a medical cannabis company called Equinox, which counts two House of Lords members amongst its directors, recently announced plans for a public float on London’s AIM marketplace.

Read more: Peers back medical cannabis company Equinox ahead of London float

Read more

Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics

Categories

  • Business

Trending Articles

  • Iceland boss Richard Walker vows to set up shop on Falkland Islands

  • Hedge fund billionaire Chris Rokos joins UK wealth exodus 

  • Britain ‘taxing itself to death,’ Burnham warned

  • £74m for branded condoms? UK must stop spaffing cash on foreign aid

  • As it happened: FTSE 100 inche up as oil holds gains; Healey says UK paying ‘Truss penalty’

More from Morning Wire

  • Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

    Business Wire
  • Organigram Reports Record Third Quarter Fiscal 2026 Results

    Business Wire
  • Vercel Appoints Amit Agarwal, Standard Template Labs CEO and former Datadog President, to Board of Directors

    Business Wire
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

    Hospitality
    Smiling man in light blue shirt holding up a glass of amber beer in a bar setting
  • Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization

    Business Wire
  • The World’s Largest AI Companies Built Deployment Arms This Year. Harbor Built One for Law

    Business Wire
  • Banning vape shops won’t fix scuzzy high streets

    Opinion
    High street vape shop Ecigwizard next to Costa Coffee and Subway, with people walking and sitting outside.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook